Adverse events of raltegravir and dolutegravir

OBJECTIVE: To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN: Prospective cohort study. METHODS: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who...

Descripción completa

Detalles Bibliográficos
Autores principales: Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Clinical Science: Concise Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566167/
https://www.ncbi.nlm.nih.gov/pubmed/28692533
http://dx.doi.org/10.1097/QAD.0000000000001590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566167/
https://www.ncbi.nlm.nih.gov/pubmed/28692533
http://dx.doi.org/10.1097/QAD.0000000000001590

Ejemplares similares